共 50 条
- [31] Supramolecular antibody-drug conjugates for combined antibody therapy and photothermal therapy targeting HER2-positive cancersINTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 278Min, Yijia论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R China Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R ChinaChen, Yu论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R China Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R ChinaWang, Lei论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R China Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R ChinaKe, Yong论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R China Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R ChinaRong, Fan论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R China Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R ChinaHe, Qunye论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R China Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R ChinaPaerhati, Pameila论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R China Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R ChinaZong, Huifang论文数: 0 引用数: 0 h-index: 0机构: Jecho Inst, Shanghai 200240, Peoples R China Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R ChinaZhu, Jianwei论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R China Jecho Inst, Shanghai 200240, Peoples R China Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R ChinaWang, Yin论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R China Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R ChinaZhang, Baohong论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R China Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Sch Pharm, Minist Educ, Shanghai 200240, Peoples R China
- [32] 177Lu-Labeled and Trastuzumab-Conjugated Gold Nanoparticles Exhibit Multivalent Binding, High Uptake and Retention in HER2-Positive Breast Cancer Cells and Potent CytotoxicityEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S530 - S530Cai, Z.论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Toronto, ON, Canada Univ Toronto, Toronto, ON, CanadaYook, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Toronto, ON, Canada Univ Toronto, Toronto, ON, CanadaLu, Y.论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Toronto, ON, Canada Univ Toronto, Toronto, ON, CanadaWinnik, M. A.论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Toronto, ON, Canada Univ Toronto, Toronto, ON, CanadaPignol, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Toronto, ON, Canada Univ Toronto, Toronto, ON, CanadaReilly, R. M.论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Toronto, ON, Canada Univ Toronto, Toronto, ON, Canada
- [33] Antibody-drug conjugates are active in patients with HER2-positive breast cancer brain metastases: where do we go from here?ESMO OPEN, 2024, 9 (05)论文数: 引用数: h-index:机构:Lin, N. U.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Med Oncol, Boston, MA 02215 USA Dana Farber Brigham Canc Ctr, Breast Oncol Program, Boston, MA 02115 USA Harvard Med Sch, Boston, MA 02115 USA Dana Farber Canc Inst, Med Oncol, Boston, MA 02215 USA
- [34] Theranostic antibody-drug conjugates for potential dual application in targeted therapy and fluorescence imaging of colorectal cancerABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256Ren, Siyuan论文数: 0 引用数: 0 h-index: 0机构: IIT, Chem, Chicago, IL 60616 USA IIT, Chem, Chicago, IL 60616 USASun, Xiang论文数: 0 引用数: 0 h-index: 0机构: IIT, Chem, Chicago, IL 60616 USA IIT, Chem, Chicago, IL 60616 USAXu, Hua论文数: 0 引用数: 0 h-index: 0机构: IIT, Chem, Chicago, IL 60616 USA IIT, Chem, Chicago, IL 60616 USATrung Hai Nguyen论文数: 0 引用数: 0 h-index: 0机构: IIT, Chem, Chicago, IL 60616 USA IIT, Chem, Chicago, IL 60616 USAKang, Chi Soo论文数: 0 引用数: 0 h-index: 0机构: IIT, Chem, Chicago, IL 60616 USA IIT, Chem, Chicago, IL 60616 USASadeghipour, Negar论文数: 0 引用数: 0 h-index: 0机构: IIT, Biomed Engn, Chicago, IL 60616 USA IIT, Chem, Chicago, IL 60616 USAXu, Xiaochun论文数: 0 引用数: 0 h-index: 0机构: IIT, Biomed Engn, Chicago, IL 60616 USA IIT, Chem, Chicago, IL 60616 USAWu, Ningjie论文数: 0 引用数: 0 h-index: 0机构: IIT, Chem, Chicago, IL 60616 USA IIT, Chem, Chicago, IL 60616 USAChen, Yu论文数: 0 引用数: 0 h-index: 0机构: IIT, Chem, Chicago, IL 60616 USA IIT, Chem, Chicago, IL 60616 USATichauer, Kenneth论文数: 0 引用数: 0 h-index: 0机构: IIT, Biomed Engn, Chicago, IL 60616 USA IIT, Chem, Chicago, IL 60616 USAMinh, David论文数: 0 引用数: 0 h-index: 0机构: IIT, Chem, Chicago, IL 60616 USA IIT, Chem, Chicago, IL 60616 USAHyun Chong论文数: 0 引用数: 0 h-index: 0机构: IIT, Chem, Chicago, IL 60616 USA IIT, Chem, Chicago, IL 60616 USA
- [35] Implementation of antibody-drug conjugates in HER2-positive solid cancers: Recent advances and future directionsBIOMEDICINE & PHARMACOTHERAPY, 2024, 174Yu, Jiazheng论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R ChinaLi, Mingyang论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R ChinaLiu, Xiandong论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R ChinaWu, Siyu论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R ChinaLi, Rong论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R ChinaJiang, Yuanhong论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R ChinaZheng, Jianyi论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R ChinaLi, Zeyu论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R ChinaXin, Kerong论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R ChinaXu, Zhenqun论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R ChinaLi, Shijie论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R ChinaChen, Xiaonan论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China
- [36] Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelatorsCONTRAST MEDIA & MOLECULAR IMAGING, 2012, 7 (02) : 254 - 264D'Huyvetter, Matthias论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, Belgium Belgian Nucl Res Ctr SCK CEN, Radiobiol Unit, Mol & Cellular Biol Expert Grp, Mol, Belgium Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, BelgiumAerts, An论文数: 0 引用数: 0 h-index: 0机构: Belgian Nucl Res Ctr SCK CEN, Radiobiol Unit, Mol & Cellular Biol Expert Grp, Mol, Belgium Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, BelgiumXavier, Catarina论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, Belgium Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, BelgiumVaneycken, Ilse论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, Belgium Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, BelgiumDevoogdt, Nick论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, Belgium Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, BelgiumGijs, Marlies论文数: 0 引用数: 0 h-index: 0机构: Belgian Nucl Res Ctr SCK CEN, Radiobiol Unit, Mol & Cellular Biol Expert Grp, Mol, Belgium Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, BelgiumImpens, Nathalie论文数: 0 引用数: 0 h-index: 0机构: Belgian Nucl Res Ctr SCK CEN, Radiobiol Unit, Mol & Cellular Biol Expert Grp, Mol, Belgium Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, BelgiumBaatout, Sarah论文数: 0 引用数: 0 h-index: 0机构: Belgian Nucl Res Ctr SCK CEN, Radiobiol Unit, Mol & Cellular Biol Expert Grp, Mol, Belgium Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, BelgiumPonsard, Bernard论文数: 0 引用数: 0 h-index: 0机构: Belgian Nucl Res Ctr SCK CEN, Radioisotopes & Silicon Prod Unit, Belgian Reactor Expert Grp 2, Mol, Belgium Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, BelgiumMuyldermans, Serge论文数: 0 引用数: 0 h-index: 0机构: Vlaams Inst Biotechnol, Dept Mol & Cell Interact, Brussels, Belgium Vrije Univ Brussel, Dept Cellular & Mol Immunol, Brussels, Belgium Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, BelgiumCaveliers, Vicky论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, Belgium UZ Brussel, Dept Nucl Med, Brussels, Belgium Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, BelgiumLahoutte, Tony论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, Belgium UZ Brussel, Dept Nucl Med, Brussels, Belgium Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, Brussels, Belgium
- [37] Assessment of theranostic potential of Lu-177-trastuzumab in HER2 expressing breast cancer patientsEUROPEAN JOURNAL OF CANCER, 2016, 54 : S28 - S28Shukla, J.论文数: 0 引用数: 0 h-index: 0机构: PGIMER Chandigarh, Dept Nucl Med & PET, Chandigarh, India PGIMER Chandigarh, Dept Nucl Med & PET, Chandigarh, IndiaBhusari, P.论文数: 0 引用数: 0 h-index: 0机构: PGIMER Chandigarh, Dept Nucl Med & PET, Chandigarh, India PGIMER Chandigarh, Dept Nucl Med & PET, Chandigarh, IndiaVatsa, R.论文数: 0 引用数: 0 h-index: 0机构: PGIMER Chandigarh, Dept Nucl Med & PET, Chandigarh, India PGIMER Chandigarh, Dept Nucl Med & PET, Chandigarh, IndiaSingh, G.论文数: 0 引用数: 0 h-index: 0机构: PGIMER Chandigarh, Dept Surg & PET, Chandigarh, India PGIMER Chandigarh, Dept Nucl Med & PET, Chandigarh, IndiaBal, A.论文数: 0 引用数: 0 h-index: 0机构: PGIMER Chandigarh, Dept Histopathol, Chandigarh, India PGIMER Chandigarh, Dept Nucl Med & PET, Chandigarh, IndiaParmar, M.论文数: 0 引用数: 0 h-index: 0机构: PGIMER Chandigarh, Dept Nucl Med & PET, Chandigarh, India PGIMER Chandigarh, Dept Nucl Med & PET, Chandigarh, IndiaDhawan, D. K.论文数: 0 引用数: 0 h-index: 0机构: Panjab Univ Chandigarh, Ctr Nucl Med, Chandigarh, India PGIMER Chandigarh, Dept Nucl Med & PET, Chandigarh, IndiaMittal, B. R.论文数: 0 引用数: 0 h-index: 0机构: PGIMER Chandigarh, Dept Nucl Med & PET, Chandigarh, India PGIMER Chandigarh, Dept Nucl Med & PET, Chandigarh, India
- [38] Preclinical evaluation of a promising novel, antibody-based 177Lu-labeled radiopharmaceutical for potential use in advanced thyroid cancerEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S440 - S441论文数: 引用数: h-index:机构:Berglund, H.论文数: 0 引用数: 0 h-index: 0机构: Uppsala Univ, Uppsala, Sweden Karolinska Inst, Stockholm, SwedenJuhlin, C.论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, Sweden Karolinska Inst, Stockholm, SwedenStenman, A.论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, Sweden Karolinska Inst, Stockholm, SwedenJha, P.论文数: 0 引用数: 0 h-index: 0机构: Uppsala Univ, Uppsala, Sweden Karolinska Inst, Stockholm, Sweden论文数: 引用数: h-index:机构:Zedenius, J.论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Stockholm, Sweden Karolinska Inst, Stockholm, SwedenNestor, M.论文数: 0 引用数: 0 h-index: 0机构: Uppsala Univ, Uppsala, Sweden Karolinska Inst, Stockholm, Sweden
- [39] Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor modelsEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 50 (01) : 168 - 183Li, Cuicui论文数: 0 引用数: 0 h-index: 0机构: Capital Med Univ, Dept Nucl Med, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 100050, Peoples R China Peking Univ First Hosp, Dept Nucl Med, 8 Xishiku Str, Beijing 100034, Peoples R China Capital Med Univ, Dept Nucl Med, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 100050, Peoples R ChinaLiu, Jun论文数: 0 引用数: 0 h-index: 0机构: Capital Med Univ, Dept Nucl Med, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 100050, Peoples R China Capital Med Univ, Dept Nucl Med, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 100050, Peoples R China论文数: 引用数: h-index:机构:Yang, Qi论文数: 0 引用数: 0 h-index: 0机构: Peking Univ First Hosp, Dept Nucl Med, 8 Xishiku Str, Beijing 100034, Peoples R China Capital Med Univ, Dept Nucl Med, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 100050, Peoples R ChinaHuang, Wenpeng论文数: 0 引用数: 0 h-index: 0机构: Peking Univ First Hosp, Dept Nucl Med, 8 Xishiku Str, Beijing 100034, Peoples R China Capital Med Univ, Dept Nucl Med, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 100050, Peoples R ChinaZhang, Mingyu论文数: 0 引用数: 0 h-index: 0机构: Capital Med Univ, Dept Nucl Med, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 100050, Peoples R China Capital Med Univ, Dept Nucl Med, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 100050, Peoples R ChinaZhou, Dandan论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Dept Oncol, NHC Key Lab Biotechnol Antibiot, Courtyard 2,Nanwei Rd, Beijing 100050, Peoples R China Capital Med Univ, Dept Nucl Med, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 100050, Peoples R ChinaWang, Rong论文数: 0 引用数: 0 h-index: 0机构: Qingdao Univ, Dept Blood Transfus, Affiliated Hosp, Qingdao 266000, Peoples R China Capital Med Univ, Dept Nucl Med, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 100050, Peoples R ChinaGong, Jianhua论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Dept Oncol, NHC Key Lab Biotechnol Antibiot, Courtyard 2,Nanwei Rd, Beijing 100050, Peoples R China Capital Med Univ, Dept Nucl Med, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 100050, Peoples R ChinaMiao, Qingfang论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Dept Oncol, NHC Key Lab Biotechnol Antibiot, Courtyard 2,Nanwei Rd, Beijing 100050, Peoples R China Capital Med Univ, Dept Nucl Med, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 100050, Peoples R ChinaKang, Lei论文数: 0 引用数: 0 h-index: 0机构: Peking Univ First Hosp, Dept Nucl Med, 8 Xishiku Str, Beijing 100034, Peoples R China Capital Med Univ, Dept Nucl Med, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 100050, Peoples R ChinaYang, Jigang论文数: 0 引用数: 0 h-index: 0机构: Capital Med Univ, Dept Nucl Med, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 100050, Peoples R China Capital Med Univ, Dept Nucl Med, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 100050, Peoples R China
- [40] Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody-Drug Conjugates in Breast CancerCANCER RESEARCH, 2022, 82 (24) : 4670 - 4679Duro-Sanchez, Santiago论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, Spain Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Bellaterra, Spain Hosp Mar Med Res Inst IMIM, Canc Res Program, Doctor Aiguader 88, Barcelona 08003, Spain Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, SpainNadal-Serrano, Mercedes论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, Spain Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, SpainLalinde-Gutierrez, Marta论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, Spain Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Bellaterra, Spain Hosp Mar Med Res Inst IMIM, Canc Res Program, Doctor Aiguader 88, Barcelona 08003, Spain Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, SpainArenas, Enrique Javier论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, Spain Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, SpainMorales, Cristina Bernado论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, Spain Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, SpainMorancho, Beatriz论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, Spain Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, SpainEscorihuela, Marta论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, Spain Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, SpainPerez-Ramos, Sandra论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, Spain Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, SpainEscriva-de-Romani, Santiago论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Breast Canc & Melanoma Grp, Barcelona, Spain Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, SpainGandullo-Sanchez, Lucia论文数: 0 引用数: 0 h-index: 0机构: Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Breast Canc & Melanoma Grp, Barcelona, Spain Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, SpainPandiella, Atanasio论文数: 0 引用数: 0 h-index: 0机构: Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain CSIC, Inst Biol Mol & Celular Canc, Salamanca, Spain Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, SpainEsteve-Codina, Anna论文数: 0 引用数: 0 h-index: 0机构: Barcelona Inst Sci & Technol, Ctr Genom Regulat, NAG CRG, Barcelona, Spain Univ Pompeu Fabra UPF, Barcelona, Spain Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, SpainRodilla, Veronica论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, Spain Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, SpainDijcks, Fred A.论文数: 0 引用数: 0 h-index: 0机构: Byondis BV, Nijmegen, Netherlands Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, SpainDokter, Wim H. A.论文数: 0 引用数: 0 h-index: 0机构: Byondis BV, Nijmegen, Netherlands Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, SpainCortes, Javier论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, Spain Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, SpainSaura, Cristina论文数: 0 引用数: 0 h-index: 0机构: Hosp Mar Med Res Inst IMIM, Canc Res Program, Doctor Aiguader 88, Barcelona 08003, Spain Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, SpainArribas, Joaquin论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, Spain Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain Hosp Mar Med Res Inst IMIM, Canc Res Program, Doctor Aiguader 88, Barcelona 08003, Spain Univ Pompeu Fabra UPF, Barcelona, Spain Inst Catalana Recerca & Estudis Avancats ICEA, Barcelona, Spain Vall dHebron Inst Oncol VHIO, Preclin & Translat Res Program, Barcelona, Spain